Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1462840rdf:typepubmed:Citationlld:pubmed
pubmed-article:1462840lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:1462840lifeskim:mentionsumls-concept:C0079652lld:lifeskim
pubmed-article:1462840lifeskim:mentionsumls-concept:C0341950lld:lifeskim
pubmed-article:1462840lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1462840pubmed:dateCreated1993-1-13lld:pubmed
pubmed-article:1462840pubmed:abstractTextIn our previous study 1), 2), 3) we reported the changes of coagulation-fibrinolysis, kallikrein-kinin system and kininase in preclampsis. In this study, we tried to obtain systemic information of chronic DIC status with regard to kallikrein-kinin system in severe preeclampsia. This systemic information was evaluated in 20 cases of normal gravidas from 28 to 42 weeks of gestation as a control by measuring plasma Thrombin/Antithrombin III complex (TAT), tissue plasminogen activator (tPA) plasminogen activator inhibitor (PAI) complex, active plasminogen inhibitor-1 (active PAI), 2PI plasmin complex (PIC). Results: The levels of plasma TAT and tPA significantly increased (TAT = 10.9 +/- 8.3 ng/ml n = 24 M +/- SD P < 0.02, tPA = 6.1 +/- 3.2 ng/ml n = 10 M +/- SD P < 0.01), tPA PAI C and active PAI markedly increased (tPA PAI C = 85.07 +/- 50.01 ng/ml n = 24 P < 0.05, active PAI = 407.4 +/- 166.0 ng/ml n = 24 P < 0.205), and PIC and D-dimer = 435.1 +/- 145.2 ng/ml n = 8 M +/- SD P < 0.001) in severe preeclampsia as compared with those of normal values (TAT = 6.1 2.0 ng/ml, tPA = 3.6 +/- 1.5 ng/ml, tPA PAI C = 57.9 +/- 30.8 ng/ml, active PAI = 304.2 +/- 148.6 ng/ml, PIC = 0.49 +/- 0.24 mg/ml, D-dimer = 282.9 +/- 75.3 ng/ml).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1462840pubmed:languageenglld:pubmed
pubmed-article:1462840pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:citationSubsetIMlld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1462840pubmed:statusMEDLINElld:pubmed
pubmed-article:1462840pubmed:issn0379-0363lld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:YoshidaAAlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:KobayashiMMlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:KikuchiYYlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:ItohNNlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:KurodaKKlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:MakiMMlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:KomatsuYYlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:SasaHHlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:MutohSSlld:pubmed
pubmed-article:1462840pubmed:authorpubmed-author:HirataJJlld:pubmed
pubmed-article:1462840pubmed:issnTypePrintlld:pubmed
pubmed-article:1462840pubmed:volume38 ( Pt 2)lld:pubmed
pubmed-article:1462840pubmed:ownerNLMlld:pubmed
pubmed-article:1462840pubmed:authorsCompleteNlld:pubmed
pubmed-article:1462840pubmed:pagination342-9lld:pubmed
pubmed-article:1462840pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:meshHeadingpubmed-meshheading:1462840-...lld:pubmed
pubmed-article:1462840pubmed:year1992lld:pubmed
pubmed-article:1462840pubmed:articleTitleStudies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.lld:pubmed
pubmed-article:1462840pubmed:affiliationDivision of Perinatal and Maternal Medicine, Akita University School of Medicine, Japan.lld:pubmed
pubmed-article:1462840pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1462840pubmed:publicationTypeComparative Studylld:pubmed